Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free VCKAW Stock Alerts

Vickers Vantage Corp. I (VCKAW) Competitors

$0.09 +0.03 (+40.35%)
As of 09/25/2026
Compare

VCKAW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Vickers Vantage Corp. I stock or one of its competitors? Vickers Vantage Corp. I's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Vickers Vantage Corp. I compare to 60 Degrees Pharmaceuticals?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Vickers Vantage Corp. I. 60 Degrees Pharmaceuticals' average media sentiment score of 1.82 beat Vickers Vantage Corp. I's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
60 Degrees Pharmaceuticals Very Positive

Summary

60 Degrees Pharmaceuticals beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Biofrontera?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

In the previous week, Biofrontera had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Vickers Vantage Corp. I. Biofrontera's average media sentiment score of 1.79 beat Vickers Vantage Corp. I's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Biofrontera Very Positive

Summary

Biofrontera beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Cingulate?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for Cingulate and 0 mentions for Vickers Vantage Corp. I. Cingulate's average media sentiment score of 1.82 beat Vickers Vantage Corp. I's score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Cingulate Very Positive

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Cingulate beats Vickers Vantage Corp. I on 2 of the 2 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Clever Leaves?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Vickers Vantage Corp. I's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Clever Leaves Neutral

Vickers Vantage Corp. I has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Clever Leaves N/A N/A N/A

Summary

Clever Leaves beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Comera Life Sciences?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

In the previous week, Vickers Vantage Corp. I's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Comera Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Comera Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

Comera Life Sciences beats Vickers Vantage Corp. I on 1 of the 1 factors compared between the two stocks.

Get Vickers Vantage Corp. I News Delivered to You Automatically

Sign up to receive the latest news and ratings for VCKAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCKAW vs. The Competition

Export
MetricVickers Vantage Corp. IPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.64B$7.33B$13.18B
Dividend YieldN/A2.62%2.52%14.03%
P/E RatioN/A792.36274.7625.59
Price / SalesN/A758.21613.3683.42
Price / CashN/A15.2228.0235.00
Price / BookN/A10.6310.536.44
Net IncomeN/A$2.84B$3.50B$360.47M
7 Day PerformanceN/A-1.18%-1.73%-1.03%
1 Month PerformanceN/A-1.15%-3.76%-3.70%
1 Year PerformanceN/A1.62%14.48%3.62%

Vickers Vantage Corp. I Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VCKAW
Vickers Vantage Corp. I
N/A$0.09
+40.4%		N/A-78.0%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
+28.1%		N/A-12.2%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
-0.5%		N/A-80.8%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
flat		N/AN/A$0.00N/AN/A14
CLVR
Clever Leaves
N/AN/AN/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:VCKAW) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...
Monument Traders Alliance | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Dec 8th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel